BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 38688610)

  • 1. Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer - a retrospective analysis.
    Piringer G; Ponholzer F; Thaler J; Bachleitner-Hofmann T; Rumpold H; de Vries A; Weiss L; Greil R; Gnant M; Öfner D
    Front Oncol; 2024; 14():1374592. PubMed ID: 38817890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Neoadjuvant Radiochemotherapy on Pathological Complete Response for Locally Advanced Rectal Cancer: A Mono Institutional Experience.
    Lucarelli M; Gentile V; Bonelli R; Pasquale G; Pizzi AD; Nicola MD; Porreca A; Genovesi D
    In Vivo; 2024; 38(3):1367-1374. PubMed ID: 38688610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes.
    DI Tommaso M; Rosa C; Caravatta L; Augurio A; Borzillo V; DI Santo S; Perrotti F; Taraborrelli M; Cianci R; Innocenti P; DI Sebastiano P; Colasante A; Angelucci D; Basti M; Sindici G; Mazzola L; Pizzicannella G; DI Bartolomeo N; Marchioni M; DI Nicola M; Genovesi D
    In Vivo; 2020; 34(3):1223-1233. PubMed ID: 32354913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
    Zhu J; Gu W; Lian P; Sheng W; Cai G; Shi D; Cai S; Zhang Z
    Radiat Oncol; 2013 May; 8():130. PubMed ID: 23718210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade : Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients.
    Rosa C; Di Tommaso M; Caravatta L; Taraborrelli M; Gasparini L; Di Guglielmo FC; Delli Pizzi A; Cinalli S; Marchioni M; Di Nicola M; Lanci C; Ausili Cefaro G; Genovesi D
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1179-1188. PubMed ID: 33026518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study.
    Ke TW; Chang SC; Liao YM; Lin CH; Chen WT; Liang JA; Li CC; Chien CR
    Anticancer Res; 2023 Dec; 43(12):5713-5722. PubMed ID: 38030192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonoperative Management of Rectal Cancer: The Watch and Wait Strategy.
    Vailati BB; São Julião GP; Habr-Gama A; Perez RO
    Surg Oncol Clin N Am; 2022 Apr; 31(2):171-182. PubMed ID: 35351272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis.
    Yang J; Wang W; Luo Y; Huang S; Fu Z
    Tech Coloproctol; 2022 Mar; 26(3):163-174. PubMed ID: 35048217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data.
    Li JY; Huang XZ; Gao P; Song YX; Chen XW; Lv XE; Fu Y; Xiao Q; Ye SY; Wang ZN
    BMC Cancer; 2021 Nov; 21(1):1214. PubMed ID: 34773999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors associated with complete pathological response after neoadjuvant treatment for rectal cancer.
    Hajer J; Rim A; Ghorbel A; Amani Y; Ines L; Asma B; Chiraz N
    Cancer Radiother; 2021 May; 25(3):259-267. PubMed ID: 33422417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes.
    Baidoun F; Elshiwy K; Elkeraie Y; Merjaneh Z; Khoudari G; Sarmini MT; Gad M; Al-Husseini M; Saad A
    Curr Drug Targets; 2021; 22(9):998-1009. PubMed ID: 33208072
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.